AF-2364 is a prospective spermicide candidate.

Hui Wang, Xiang-Xiang Chen, Li-Rong Wang, Yun-Dong Mao, Zuo-Min Zhou, Jia-Hao Sha

Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing 210029, China.

Asian journal of andrology 2010 May

filter terms:

AbstractInhibition of sperm motility has recently become a promising target for male contraceptive development. AF-2364, an analogue of Lonidamine (LND), had a contraceptive effect when orally administered to adult Sprague-Dawley rats. LND can also target mitochondria to inhibit oxygen consumption and block energy metabolism in tumour cells. However, there are no reports of the effects of AF-2364 on human sperm function. Herein we describe the action of AF-2364 on human sperm in vitro, as well as the mechanisms involved. AF-2364 specifically blocked human sperm motility in vitro. Further experiments revealed that AF-2364 can target sperm mitochondrial permeability transition (MPT) pores to induce the loss of sperm mitochondrial membrane potential (DeltaPsim) and decrease ATP generation; however, no significant changes in the cytoskeletal network or the human sperm proteome were detected after exposure to AF-2364. Incubation of AF-2364 with other human or mouse cell lines indicated that the spermicidal effect at the lower concentration was specific. In summary, the spermicidal effect of AF-2364 involves direct action on sperm MPT pores, and this compound should be further investigated as a new spermicide candidate.

Citation

Hui Wang, Xiang-Xiang Chen, Li-Rong Wang, Yun-Dong Mao, Zuo-Min Zhou, Jia-Hao Sha. AF-2364 is a prospective spermicide candidate. Asian journal of andrology. 2010 May;12(3):322-35